Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab [Corrigendum]
2017 ◽
Vol Volume 10
◽
pp. 2751-2760
◽
2014 ◽
Vol 13
(11)
◽
pp. 1100-1107
◽
2010 ◽
Vol 333
(1)
◽
pp. 152-160
◽
2018 ◽
Vol 39
(12)
◽
pp. 2097-2106
◽
2019 ◽
Vol 9
(3)
◽
pp. 277-278
◽
Keyword(s):